Bank of America’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Buy |
2,008,004
+17,180
| +0.9% | +$24.6K | ﹤0.01% | 3728 |
|
|
2025
Q1 | $3.19M | Buy |
1,990,824
+313,182
| +19% | +$501K | ﹤0.01% | 3582 |
|
|
2024
Q4 | $6.04M | Sell |
1,677,642
-358,591
| -18% | -$1.29M | ﹤0.01% | 2880 |
|
|
2024
Q3 | $11.6M | Buy |
2,036,233
+267,734
| +15% | +$1.53M | ﹤0.01% | 2513 |
|
|
2024
Q2 | $8.17M | Sell |
1,768,499
-86,659
| -5% | -$400K | ﹤0.01% | 2720 |
|
|
2024
Q1 | $15.2M | Buy |
1,855,158
+180,061
| +11% | +$1.47M | ﹤0.01% | 2204 |
|
|
2023
Q4 | $9.46M | Buy |
1,675,097
+1,629,756
| +3,594% | +$9.21M | ﹤0.01% | 2466 |
|
|
2023
Q3 | $84.3K | Buy |
45,341
+11,672
| +35% | +$21.7K | ﹤0.01% | 5435 |
|
|
2023
Q2 | $92.6K | Sell |
33,669
-17,819
| -35% | -$49K | ﹤0.01% | 5389 |
|
|
2023
Q1 | $162K | Sell |
51,488
-143,668
| -74% | -$451K | ﹤0.01% | 5246 |
|
|
2022
Q4 | $1.15M | Buy |
195,156
+55,969
| +40% | +$330K | ﹤0.01% | 4093 |
|
|
2022
Q3 | $1.22M | Buy |
139,187
+77,676
| +126% | +$681K | ﹤0.01% | 4047 |
|
|
2022
Q2 | $464K | Sell |
61,511
-42,267
| -41% | -$319K | ﹤0.01% | 4783 |
|
|
2022
Q1 | $2.52M | Buy |
103,778
+2,105
| +2% | +$51.1K | ﹤0.01% | 3788 |
|
|
2021
Q4 | $3.27M | Buy |
101,673
+80,122
| +372% | +$2.58M | ﹤0.01% | 3485 |
|
|
2021
Q3 | $963K | Sell |
21,551
-12,754
| -37% | -$570K | ﹤0.01% | 4392 |
|
|
2021
Q2 | $1.3M | Sell |
34,305
-14,469
| -30% | -$547K | ﹤0.01% | 4042 |
|
|
2021
Q1 | $1.8M | Buy |
48,774
+42,644
| +696% | +$1.58M | ﹤0.01% | 3827 |
|
|
2020
Q4 | $203K | Buy |
+6,130
| New | +$203K | ﹤0.01% | 4880 |
|